FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Context drives trial-finder

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

It's a tough nut to crack: So many trials, so many prospective subjects...but how to get them together? A San Francisco-based project has joined the ranks of Quintiles (online), Healogica (iPhone), and TrialX (Twitter) in spreading word of clinical trials to the masses.

The Medpedia Project targets "appropriate contexts," organizers say in an announcement. The platform pushes trial information to appear alongside an article covering the same condition, for example, or to the personalized feed of a patient who has the condition. Online patient communities are another push target.

The project, which launched a year ago, includes the free online platform that aims to provide easy-to-understand medical information to the general public as well as connections with researchers and medical specialists. Among project participants are Harvard, Stanford and UC Berkeley.

The push platform links with the 80,000-trial ClinicalTrials.gov registry, which updates daily. The platform also includes an online medical encyclopedia, a directory of health professionals and organizations, and communities of interest. News, alerts and a QA forum are also part of the platform.

- here's the announcement

Related Articles:
Facebook privacy upgrade foretells trial tool
Social media shake pharma order
Pharma, social media continue dance
Social media transcend the professional/personal line


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about clinical trials   pharmaceutical social media